A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

December 27, 2018

Study Completion Date

December 27, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

SAR425899

"Pharmaceutical form: Solution for injection~Route of administration: Subcutaneous"

DRUG

Placebo

"Pharmaceutical form: Solution for injection~Route of administration: Subcutaneous"

Trial Locations (2)

Investigational Site Number 8400001, Orlando

Investigational Site Number 8400002, Baton Rouge